Login / Signup

NIR-II Organic Nanotheranostics for Precision Oncotherapy.

Hanming DaiXiaorui WangJinjun ShaoWenjun WangXiaozhou MouXiaochen Dong
Published in: Small (Weinheim an der Bergstrasse, Germany) (2021)
Precision oncotherapy can remove tumors without causing any apparent iatrogenic damage or irreversible side effects to normal tissues. Second near-infrared (NIR-II) nanotheranostics can simultaneously perform diagnostic and therapeutic modalities in a single nanoplatform, which exhibits prominent perspectives in tumor precision treatment. Among all NIR-II nanotheranostics, NIR-II organic nanotheranostics have shown an exceptional promise for translation in clinical tumor treatment than NIR-II inorganic nanotheranostics in virtue of their good biocompatibility, excellent reproducibility, desirable excretion, and high biosafety. In this review, recent progress of NIR-II organic nanotheranostics with the integration of tumor diagnosis and therapy is systematically summarized, focusing on the theranostic modes and performances. Furthermore, the current status quo, problems, and challenges are discussed, aiming to provide a certain guiding significance for the future development of NIR-II organic nanotheranostics for precision oncotherapy.
Keyphrases
  • photodynamic therapy
  • drug release
  • fluorescence imaging
  • fluorescent probe
  • current status
  • magnetic resonance imaging
  • water soluble
  • stem cells
  • mental health
  • bone marrow
  • diffusion weighted imaging